Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
999.6 INR | -2.14% | -5.44% | +17.06% |
05-03 | Glenmark Pharmaceuticals Limited Appoints Shweta Munjal as Chief Communications & CSR Officer | CI |
04-29 | Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.06% | 3.45B | |
+18.67% | 43.74B | |
+24.05% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-8.98% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.47B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Nomura Adjusts Glenmark Pharmaceuticals’ Price Target to INR909 From INR841, Keeps at Neutral